Company profile: Cavidi
1.1 - Company Overview
Company description
- Provider of HIV viral load monitoring diagnostics and BOLD-based immunoassay signal amplification solutions, including Exazym reagent kits for attomole-level biomarker detection (up to 100x amplification), ClickChem conjugation, polymerase reaction and biotin detection kits, plus research services and collaborations on low-abundance biomarker discovery and immunoassay development.
Products and services
- BOLD (Binding Oligo Ladder Detection): Research-grade methodology that amplifies immunoassay signals by up to 100x, applicable across various immunoassays
- Exazym Reagent Kits: Laboratory-grade kits engineered for attomole-level detection of low-abundance biomarkers in ELISA workflows, enabling up to 100x signal amplification
- Research Services and Collaborations: Consultancy-grade programs advancing low-abundance biomarker discovery, detection, and immunoassay development using BOLD technology through collaborative engagements.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cavidi
Taxis Pharmaceuticals
HQ: United States
Website
- Description: Provider of anti-infective pharmaceuticals focused on discovery and development of novel agents, including TXA709, an oral anti-MRSA agent targeting the FtsZ bacterial cell division protein (completed Phase I), and efflux pump inhibitors for Gram-negative MDR pathogens by inhibiting resistance efflux pumps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Taxis Pharmaceuticals company profile →
InDevR
HQ: United States
Website
- Description: Provider of microarray technologies and novel solutions for the life science industry, including ampliPHOX Colorimetric Detection Technology for identification and differentiation of viruses such as Crimean-Congo hemorrhagic fever virus.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InDevR company profile →
Anadys Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics for chronic hepatitis C, developing ANA598, a direct-acting antiviral (DAA), and resuming clinical development of ANA773.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anadys Pharmaceuticals company profile →
Cytophage
HQ: Canada
Website
- Description: Provider of bacteriophage development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytophage company profile →
Now Diagnostics
HQ: United States
Website
- Description: Provider of rapid, single-drop-of-blood diagnostic tests delivering results within minutes, including ADEXUSDx assays for COVID-19 antibodies, hCG for early pregnancy, syphilis antibodies, elevated acetaminophen, H-FABP for myocardial damage, and methanol detection in blood, plasma, or serum.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Now Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cavidi
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cavidi
2.2 - Growth funds investing in similar companies to Cavidi
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cavidi
4.2 - Public trading comparable groups for Cavidi
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →